The Finger – A tried and true method to save lives

Famous Fingers raising awareness for Prostate Cancer



TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.

In order to raise awareness and encourage men to get checked, Prostate Cancer Canada is testing the Famous Fingers Collection (a line of latex gloves) modeled after famous fingers to research which men prefer. Famous Fingers like that of Babe Ruth, Abraham Lincoln, or others. The collection can be viewed at famousfingers.ca and is designed to trigger a broader discussion around a serious topic that men traditionally prefer to avoid.
 
 

“It’s about normalizing the conversation around prostate exams and stressing the importance of detecting prostate cancer early,” said Peter Coleridge, President and CEO of Prostate Cancer Canada. “We know that men are uncomfortable with the idea of getting their prostates checked, but early detection can save lives. Any alternative to being examined by your doctor is quite absurd, which the campaign captures perfectly. Would you prefer to have your prostate checked by your doctor, or by Big Foot? We’ll let you decide.”
 
One in seven Canadian men will be diagnosed with prostate cancer in their lifetime, and more than 4,000 men were estimated to die from the disease in 2017, but that story is changing. Since 2001, that number has been decreasing by an average of 3.3% per year, largely attributed to early diagnosis and better treatment options. Men in their 40s are encouraged to get a baseline PSA test and those at a higher risk for prostate cancer should talk to their doctor even before age 40.
 
“Men aren’t talking about prostate health. They’re not fascinated by it the way they are with sports, movies and music. So, we’ve combined the thing that they don’t like to talk about, with the things that they do, to create a humourous and fun way for guys to start thinking about their prostate health,” said David Leonard, CEO McCann Worldgroup Canada.” Our goal is to get men talking to each other and their doctors, and to turn an awkward conversation into the kind of conversation they have every day.”

While elevated PSA levels don’t always signify prostate cancer, they often do. Generally, prostate cancer exhibits no symptoms at an early stage and it is at this stage that the PSA tests paired with the DRE can be a valuable tool to alert men to the presence of prostate cancer when longer term survival rates are at their highest – close to 100 per cent, five years after a diagnosis.
 
Adds Coleridge, “Consulting a medical professional and getting a baseline PSA test is our best current method to flag a potential issue with their prostate.”
 
The multi-platform integrated campaign is currently running and consists of digital video, newspaper, resto-bar posters, radio, PR and social all driving to famousfingers.ca. Men and women alike are invited to join the conversation using #famousfingers.
 
For more information and to view the campaign you can visit famousfingers.ca.
 
Some facts about PSA testing
 
What is the PSA Test? 
The PSA test is a simple blood test that measures the amount of prostate specific antigen (PSA) in your blood. A higher PSA level doesn’t always mean a man has prostate cancer, but it is an important indicator that something may be wrong and can spur on further investigation. Learn more.
 
How can the PSA test help? 
Early detection of prostate cancer saves lives. When detected early, the survival rate for prostate cancer is close to 100%. Without testing for prostate cancer, men are at a higher risk for diagnosis of more advanced and dangerous prostate cancer. Learn more.
 
What is the Digital Rectal Exam? 
In a digital rectal exam (DRE), your doctor will feel the size and shape of the prostate by inserting a gloved and lubricated finger into the rectum. This test permits the doctor to feel the area where more prostate cancers are found. Learn more.
 
About Prostate Cancer Canada 

Prostate Cancer Canada is the leading national foundation dedicated to the elimination of the most common cancer in men through research, advocacy, education, support and awareness. As the largest charitable investor in prostate cancer research in Canada, Prostate Cancer Canada is committed to continuous discovery in the areas of prevention, diagnosis, treatment, and support.
 
Prostate Cancer Canada is proud to have been named one of Canada’s top 3 health charities for efficiency and financial transparency in the Financial Post’s 2017 Charities of the Year list. Learn more at prostatecancer.ca
 
About McCann Worldgroup Canada 

McCann Worldgroup Canada (MWGC) is a leading integrated marketing communications agency comprised of McCann (advertising), MRM//McCann (digital marketing/relationship management), Momentum Worldwide (brand experience), McCann Health (professional/dtc communications) and CRAFT (global adaptation and production). With offices in Vancouver, Calgary, Toronto and Montreal, the agency has been continuously ranked among the top in Canada since 1915. We are part of the Interpublic Group (NYSE: IPG).
 
MWGC creates meaningful roles for brands in people’s lives and improves the performance and influence of their clients. mccann.ca.
 
For additional Information and/or interviews, please contact:

Arden Bagni 
Manager, Communications
Prostate Cancer Canada
arden.bagni@prostatecancer.ca 
416-441-2131, ext. 264
 
Caroline Murphy 
McCann Worldgroup Canada
caroline.murphy@mccann.com 
416.846.8829
Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 



PCC Spotlight
Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More

Prostate Cancer Canada launches first national program in radioligand therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.
More


Click here for news archive